Latest Insider Transactions at Natera, Inc. (NTRA)
This section provides a real-time view of insider transactions for Natera, Inc. (NTRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Natera, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Natera, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,024
-0.51%
|
$643,072
$128.84 P/Share
|
|
Sep 13
2024
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct |
2,614
-24.7%
|
$331,978
$127.68 P/Share
|
|
Sep 13
2024
|
Rowan E Chapman |
BUY
Exercise of conversion of derivative security
|
Direct |
2,614
+19.81%
|
$245,716
$94.14 P/Share
|
|
Aug 15
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
12,000
-4.01%
|
$1,452,000
$121.01 P/Share
|
|
Aug 15
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,583
-1.36%
|
$664,377
$119.4 P/Share
|
|
Aug 13
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
3,956
-3.34%
|
$458,896
$116.67 P/Share
|
|
Aug 12
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.78%
|
-
|
|
Aug 12
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.22%
|
$307,800
$114.42 P/Share
|
|
Aug 08
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Exercise of conversion of derivative security
|
Direct |
190,000
+11.37%
|
$950,000
$5.4 P/Share
|
|
Jul 31
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,866
-2.53%
|
$184,734
$99.65 P/Share
|
|
Jul 31
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.09%
|
$500
$5.4 P/Share
|
|
Jul 29
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,238
-1.65%
|
$126,276
$102.77 P/Share
|
|
Jul 29
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,084
-1.94%
|
$416,568
$102.77 P/Share
|
|
Jul 29
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
929
-0.85%
|
$94,758
$102.77 P/Share
|
|
Jul 29
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,196
-1.05%
|
$121,992
$102.77 P/Share
|
|
Jul 29
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,057
-0.51%
|
$107,814
$102.77 P/Share
|
|
Jul 26
2024
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
143
+0.9%
|
-
|
|
Jul 26
2024
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
234
+6.16%
|
-
|
|
Jul 26
2024
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.38%
|
-
|
|
Jul 26
2024
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
206
+0.31%
|
-
|
|
Jul 26
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
751
-0.99%
|
$76,602
$102.18 P/Share
|
|
Jul 25
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
690
-0.9%
|
$72,450
$105.29 P/Share
|
|
Jul 24
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
918
-1.19%
|
$96,390
$105.53 P/Share
|
|
Jul 23
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
499
-0.64%
|
$53,393
$107.4 P/Share
|
|
Jul 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,059
-1.34%
|
$111,195
$105.16 P/Share
|
|
Jul 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.56%
|
-
|
|
Jul 22
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
815
-0.39%
|
$85,575
$105.16 P/Share
|
|
Jul 22
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,638
-1.24%
|
$276,990
$105.16 P/Share
|
|
Jul 22
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
549
-0.5%
|
$57,645
$105.16 P/Share
|
|
Jul 22
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
549
-0.48%
|
$57,645
$105.16 P/Share
|
|
Jul 21
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+1.45%
|
-
|
|
Jul 21
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+0.31%
|
-
|
|
Jul 21
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
143
+0.05%
|
-
|
|
Jul 21
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,774
+0.83%
|
-
|
|
Jul 20
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+1.95%
|
-
|
|
Jul 20
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.41%
|
-
|
|
Jul 20
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.06%
|
-
|
|
Jul 20
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.58%
|
-
|
|
Jul 15
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,496
-1.29%
|
$610,056
$111.91 P/Share
|
|
Jul 01
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,983
-6.23%
|
$538,164
$108.37 P/Share
|
|
Jul 01
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
37,500
-5.19%
|
$4,050,000
$108.59 P/Share
|
|
Jul 01
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,723
-1.3%
|
$294,084
$108.37 P/Share
|
|
Jul 01
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.44%
|
$291,600
$108.98 P/Share
|
|
Jun 28
2024
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
2,964
+16.02%
|
-
|
|
Jun 28
2024
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
2,964
+47.09%
|
-
|
|
Jun 28
2024
|
Rowan E Chapman |
BUY
Grant, award, or other acquisition
|
Direct |
2,964
+27.11%
|
-
|
|
Jun 28
2024
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
2,964
+6.09%
|
-
|
|
Jun 28
2024
|
Gail Boxer Marcus |
BUY
Grant, award, or other acquisition
|
Direct |
2,964
+12.07%
|
-
|
|
Jun 28
2024
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
2,964
+4.34%
|
-
|
|
Jun 28
2024
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
2,964
+50.0%
|
-
|